![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1354353
ÀúÄڹ߶ó¹ÎÇ÷Áõ(ºñŸ¹Î B12 °áÇÌ) ÀÓ»ó½ÃÇè ºÐ¼® : ÀÓ»ó½ÃÇè ´Ü°èº°, ÀÓ»ó½ÃÇè ÇöȲº°, Æò°¡ÁöÇ¥º°, ½ºÆù¼ À¯Çüº°, Áö¿ªº°(2023³â Ãֽе¿Çâ)Hypocobalaminemia (Vitamin B12) Deficiency Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update |
ÀÌ º¸°í¼´Â ÀúÄڹ߶ó¹ÎÇ÷Áõ(ºñŸ¹Î B12 °áÇÌÁõ) ÀÓ»ó½ÃÇè ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² ´Ü°èº°, Àλó½ÃÇè ÇöȲº°, Æò°¡ÁöÇ¥º°, ½ºÆù¼ À¯Çüº°, Áö¿ªº° µ¿Çâ, ÁÖ¿ä ±â¾÷, ÀÓ»ó½ÃÇè ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
GlobalData's clinical trial report, "Hypocobalaminemia (Vitamin B12) Deficiency Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update" provides an overview of Hypocobalaminemia (Vitamin B12) Deficiency Clinical trials scenario. This report provides top line data relating to the clinical trials on Hypocobalaminemia (Vitamin B12) Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.